Beyond Helicobacter pylori: Current Insights into H. pylori-Naive Gastric Cancer
Digestion · 16.03.2026 · 1-17
DOI: 10.1159/000551483 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Digestion, online erschienen am 16.03.2026. Verfasst von Samuel W D Woo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Faculty of Medicine, The Chinese Univ…. Die Arbeit nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background: The increasing global incidence of Helicobacter pylori-naive gastric cancer (HPnGC) has established it as a clinical entity warranting further study of its diagnosis, pathogenesis, aetiologies, classifications, and management. Summary: HPnGC is an emerging and distinct clinical entity, with its relative burden increasing as global efforts for H. pylori eradication succeeds. The cancer is linked to specific aetiologies such as Epstein-Barr virus, autoimmune gastritis, and certain hereditary cancer predisposition syndromes, and is also linked to more aggressive histological subtypes, unfavourable anatomical locations, advanced stages at diagnosis, and potentially carries a poorer prognosis compared to its H. pylori-positive counterpart. Diagnosis requires stringent multi-modal confirmation of absent infection. Currently, endoscopic, surgical, and systemic treatments are similar to those for H. pylori-positive gastric cancer. Key Messages: This review demonstrates wide knowledge gaps and areas requiring further clarification. Accurate diagnosis remains challenging due to the absence of standardized criteria, highlighting the need for a robust diagnostic framework. Furthermore, it is imperative for further research into the different molecular subtypes and carcinogenic mechanisms to identify cost-effective surveillance methods and effective treatment strategies that contribute to the development of a comprehensive and practical clinical guideline.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong, China.
- Department of Gastroenterology and Hepatology, Division of Medicine, Singapore General Hospital, Singapore, Singapore.
- Duke-NUS Medical School, Singapore, Singapore.
- Division of Upper Gastrointestinal and Metabolic Surgery, Department of Surgery, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong, China.
- Cancer Genetics Service, Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
- Institute of Digestive Disease, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong, China.
Zitieren
APA
Woo, S. W. D., Yeap, V. S. X., Hau, V. S. F., Tan, Y. B., Lau, L. H. S., Yip, H. C., Lui, R., Chan, S. M., & Chiu, P. (2026). Beyond Helicobacter pylori: Current Insights into H. pylori-Naive Gastric Cancer. Digestion, 1-17. https://doi.org/10.1159/000551483
Vancouver
Woo SWD, Yeap VSX, Hau VSF, Tan YB, Lau LHS, Yip HC, et al. Beyond Helicobacter pylori: Current Insights into H. pylori-Naive Gastric Cancer. Digestion. 2026:1-17. doi:10.1159/000551483
BibTeX
@article{Woo2026,
author = {Woo, Samuel W D and Yeap, Valerie S X and Hau, Victor S F and Tan, Yu Bin and Lau, Louis H S and Yip, Hon Chi and Lui, Rashid and Chan, Shannon Melissa and Chiu, Philip},
title = {Beyond Helicobacter pylori: Current Insights into H. pylori-Naive Gastric Cancer},
journal = {Digestion},
year = {2026},
pages = {1--17},
doi = {10.1159/000551483}
}
EUVIMED